Genomic Landscape and Molecular Risk in Patients with Advanced Myelofibrosis Treated within the Multicenter Phase Ib/II MPNSG0212 (POMINC) Trial
2021
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI